• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从阿尔法到奥密克戎:严重急性呼吸综合征冠状病毒2的不同关注变异株如何影响世界

From Alpha to Omicron: How Different Variants of Concern of the SARS-Coronavirus-2 Impacted the World.

作者信息

Andre Mickensone, Lau Lee-Seng, Pokharel Marissa D, Ramelow Julian, Owens Florida, Souchak Joseph, Akkaoui Juliet, Ales Evan, Brown Harry, Shil Rajib, Nazaire Valeria, Manevski Marko, Paul Ngozi P, Esteban-Lopez Maria, Ceyhan Yasemin, El-Hage Nazira

机构信息

Herbert Wertheim College of Medicine, Biomedical Sciences Program Florida International University, Miami, FL 33199, USA.

出版信息

Biology (Basel). 2023 Sep 21;12(9):1267. doi: 10.3390/biology12091267.

DOI:10.3390/biology12091267
PMID:37759666
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10525159/
Abstract

SARS-CoV-2, the virus that causes COVID-19, is prone to mutations and the generation of genetic variants. Since its first outbreak in 2019, SARS-CoV-2 has continually evolved, resulting in the emergence of several lineages and variants of concern (VOC) that have gained more efficient transmission, severity, and immune evasion properties. The World Health Organization has given these variants names according to the letters of the Greek Alphabet, starting with the Alpha (B.1.1.7) variant, which emerged in 2020, followed by the Beta (B.1.351), Gamma (P.1), Delta (B.1.617.2), and Omicron (B.1.1.529) variants. This review explores the genetic variation among different VOCs of SARS-CoV-2 and how the emergence of variants made a global impact on the pandemic.

摘要

导致 COVID-19 的病毒 SARS-CoV-2 易于发生突变并产生基因变体。自 2019 年首次爆发以来,SARS-CoV-2 不断进化,导致出现了几个谱系和令人担忧的变体(VOC),这些变体具有更强的传播效率、致病性和免疫逃逸特性。世界卫生组织根据希腊字母表中的字母为这些变体命名,从 2020 年出现的 Alpha(B.1.1.7)变体开始,随后是 Beta(B.1.351)、Gamma(P.1)、Delta(B.1.617.2)和 Omicron(B.1.1.529)变体。本综述探讨了 SARS-CoV-2 不同 VOC 之间的基因变异,以及变体的出现如何对全球大流行产生影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75e9/10525159/23dbe4f1ed4a/biology-12-01267-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75e9/10525159/57f37acb6e88/biology-12-01267-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75e9/10525159/009b5c4da75b/biology-12-01267-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75e9/10525159/23dbe4f1ed4a/biology-12-01267-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75e9/10525159/57f37acb6e88/biology-12-01267-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75e9/10525159/009b5c4da75b/biology-12-01267-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75e9/10525159/23dbe4f1ed4a/biology-12-01267-g003.jpg

相似文献

1
From Alpha to Omicron: How Different Variants of Concern of the SARS-Coronavirus-2 Impacted the World.从阿尔法到奥密克戎:严重急性呼吸综合征冠状病毒2的不同关注变异株如何影响世界
Biology (Basel). 2023 Sep 21;12(9):1267. doi: 10.3390/biology12091267.
2
The Biological Functions and Clinical Significance of SARS-CoV-2 Variants of Corcern.关注的新冠病毒变异株的生物学功能及临床意义
Front Med (Lausanne). 2022 May 20;9:849217. doi: 10.3389/fmed.2022.849217. eCollection 2022.
3
A comprehensive review on Covid-19 Omicron (B.1.1.529) variant.关于新冠病毒奥密克戎(B.1.1.529)变体的全面综述。
Saudi J Biol Sci. 2022 Sep;29(9):103372. doi: 10.1016/j.sjbs.2022.103372. Epub 2022 Jul 15.
4
Update on SARS-CoV-2 Omicron Variant of Concern and Its Peculiar Mutational Profile.关于关注的 SARS-CoV-2 奥密克戎变异株及其特殊突变特征的最新信息。
Microbiol Spectr. 2022 Apr 27;10(2):e0273221. doi: 10.1128/spectrum.02732-21. Epub 2022 Mar 30.
5
Analysis of SARS-CoV-2 in Nasopharyngeal Samples from Patients with COVID-19 Illustrates Population Variation and Diverse Phenotypes, Placing the Growth Properties of Variants of Concern in Context with Other Lineages.对 COVID-19 患者鼻咽样本中的 SARS-CoV-2 的分析说明了人群变异和不同表型,并将关注变体的生长特性与其他谱系联系起来。
mSphere. 2022 Jun 29;7(3):e0091321. doi: 10.1128/msphere.00913-21. Epub 2022 May 2.
6
Molecular dynamics simulations of the delta and omicron SARS-CoV-2 spike - ACE2 complexes reveal distinct changes between both variants.德尔塔和奥密克戎新冠病毒刺突蛋白-血管紧张素转换酶2复合物的分子动力学模拟揭示了两种变体之间的明显变化。
Comput Struct Biotechnol J. 2022;20:1168-1176. doi: 10.1016/j.csbj.2022.02.015. Epub 2022 Feb 26.
7
Across-the-board review on Omicron SARS-CoV-2 variant.对奥密克戎新冠病毒变异株的全面审查。
Inflammopharmacology. 2025 Jan;33(1):1-10. doi: 10.1007/s10787-024-01627-4. Epub 2024 Dec 23.
8
SARS-CoV-2 Omicron Variant Genomic Sequences and Their Epidemiological Correlates Regarding the End of the Pandemic: In Silico Analysis.严重急性呼吸综合征冠状病毒2型奥密克戎变异株基因组序列及其与大流行结束相关的流行病学关联:计算机模拟分析
JMIR Bioinform Biotechnol. 2023 Jan 10;4:e42700. doi: 10.2196/42700. eCollection 2023.
9
Evolutionary and Phylogenetic Dynamics of SARS-CoV-2 Variants: A Genetic Comparative Study of Taiyuan and Wuhan Cities of China.SARS-CoV-2 变异株的进化与系统发育动态:中国太原市与武汉市的遗传比较研究。
Viruses. 2024 Jun 3;16(6):907. doi: 10.3390/v16060907.
10
An evolutionary insight into Severe Acute Respiratory Syndrome Coronavirus 2 Omicron variant of concern.对严重急性呼吸综合征冠状病毒2奥密克戎变异株的进化洞察。
Virus Res. 2022 Jun;314:198753. doi: 10.1016/j.virusres.2022.198753. Epub 2022 Mar 22.

引用本文的文献

1
Differences in the Clinical Course of COVID-19 in Patients Hospitalized in the 2023/2024 and 2024/2025 Seasons.2023/2024年和2024/2025年住院的COVID-19患者临床病程差异。
J Clin Med. 2025 Aug 25;14(17):5992. doi: 10.3390/jcm14175992.
2
Assessing participants' experiences with the COVID-19 symptom diary in a clinical trial.在一项临床试验中评估参与者使用新冠病毒症状日记的体验。
J Patient Rep Outcomes. 2025 Aug 11;9(1):99. doi: 10.1186/s41687-025-00901-5.
3
Clinical Evaluation of the Healgen Rapid COVID-19 Antigen Test as a Point-of-Care Diagnostic Tool.

本文引用的文献

1
Significant Broad-Spectrum Antiviral Activity of Bi121 against Different Variants of SARS-CoV-2.Bi121 对 SARS-CoV-2 不同变体具有显著的广谱抗病毒活性。
Viruses. 2023 May 31;15(6):1299. doi: 10.3390/v15061299.
2
Genomic Surveillance for SARS-CoV-2 Variants: Circulation of Omicron Lineages - United States, January 2022-May 2023.SARS-CoV-2 变异株的基因组监测:奥密克戎谱系的传播-美国,2022 年 1 月-2023 年 5 月。
MMWR Morb Mortal Wkly Rep. 2023 Jun 16;72(24):651-656. doi: 10.15585/mmwr.mm7224a2.
3
Clinical virology and effect of Covid-19 vaccination and monoclonal antibodies against highly infectious SARS- CoV-2 omicron sub variant BF.7 (BA.5.2.1.7): A systematic review.
Healgen新冠病毒快速抗原检测作为即时诊断工具的临床评估
Immun Inflamm Dis. 2025 Jul;13(7):e70228. doi: 10.1002/iid3.70228.
4
Megakaryocyte phenotyping in response to SARS-CoV-2 variants.巨核细胞对新冠病毒变异株的表型分析
Platelets. 2025 Dec;36(1):2532459. doi: 10.1080/09537104.2025.2532459. Epub 2025 Jul 23.
5
A 22 month prospective assessment of neutralizing and IgG antibody levels against SARS-CoV-2 variants following homologous and heterologous BNT162b2 boosting.同源和异源BNT162b2加强免疫后针对SARS-CoV-2变异株的中和抗体和IgG抗体水平的22个月前瞻性评估。
Sci Rep. 2025 Jul 1;15(1):21175. doi: 10.1038/s41598-025-05377-3.
6
Bayesian changepoint detection for epidemic models.用于流行病模型的贝叶斯变点检测
Sci Rep. 2025 Jul 1;15(1):20545. doi: 10.1038/s41598-025-01944-w.
7
Association of RBD mutations with COVID-19 disease severity in the Iranian population.伊朗人群中RBD突变与COVID-19疾病严重程度的关联。
Virus Genes. 2025 Jun 26. doi: 10.1007/s11262-025-02168-w.
8
The pleiotropic anti-cancer, antiviral, and anti-neuro-immunomodulatory role of methanolic neem bark extract.甲醇提取物印楝树皮的多效抗癌、抗病毒和抗神经免疫调节作用。
J Nat Med. 2025 Jun 19. doi: 10.1007/s11418-025-01924-4.
9
Beyond the Pandemic Era: Recent Advances and Efficacy of SARS-CoV-2 Vaccines Against Emerging Variants of Concern.后疫情时代:SARS-CoV-2疫苗针对新出现的关注变异株的最新进展与效果
Vaccines (Basel). 2025 Apr 17;13(4):424. doi: 10.3390/vaccines13040424.
10
Microneedle Delivery of Heterologous Microparticulate COVID-19 Vaccine Induces Cross Strain Specific Antibody Levels in Mice.异源微粒新冠疫苗的微针递送可诱导小鼠产生跨毒株特异性抗体水平。
Vaccines (Basel). 2025 Apr 1;13(4):380. doi: 10.3390/vaccines13040380.
临床病毒学以及 COVID-19 疫苗和单克隆抗体对高传染性 SARS-CoV-2 奥密克戎变异株 BF.7(BA.5.2.1.7)的影响:系统评价。
Virology. 2023 Jul;584:38-43. doi: 10.1016/j.virol.2023.04.007. Epub 2023 May 19.
4
Substantial Neutralization Escape by SARS-CoV-2 Omicron Variants BQ.1.1 and XBB.1.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)奥密克戎变种BQ.1.1和XBB.1的显著中和逃逸
N Engl J Med. 2023 Feb 16;388(7):662-664. doi: 10.1056/NEJMc2214314. Epub 2023 Jan 18.
5
Coronavirus variant XBB.1.5 rises in the United States - is it a global threat?新冠病毒变异株XBB.1.5在美国呈上升趋势——它是全球威胁吗?
Nature. 2023 Jan;613(7943):222-223. doi: 10.1038/d41586-023-00014-3.
6
BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants.BA.2 和 BA.5 奥密克戎在免疫学上与 BA.1 奥密克戎和前奥密克戎变体不同。
Nat Commun. 2022 Dec 13;13(1):7701. doi: 10.1038/s41467-022-35312-3.
7
Combining predictive models with future change scenarios can produce credible forecasts of COVID-19 futures.将预测模型与未来变化情景相结合,可以对 COVID-19 的未来产生可信的预测。
PLoS One. 2022 Nov 15;17(11):e0277521. doi: 10.1371/journal.pone.0277521. eCollection 2022.
8
Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5.SARS-CoV-2 奥密克戎 BA.2 亚系,包括 BA.4 和 BA.5 的病毒学特征。
Cell. 2022 Oct 13;185(21):3992-4007.e16. doi: 10.1016/j.cell.2022.09.018. Epub 2022 Sep 14.
9
Governing COVID-19: analyzing the effects of policy responses on food systems in Tanzania.管控新冠疫情:分析坦桑尼亚应对政策对粮食系统的影响
Agric Food Secur. 2022;11(1):47. doi: 10.1186/s40066-022-00383-4. Epub 2022 Sep 9.
10
COVID-19 and children.新型冠状病毒肺炎与儿童。
Science. 2022 Sep 9;377(6611):1144-1149. doi: 10.1126/science.ade1675. Epub 2022 Sep 8.